80NSSC23CA171↗

Name: 80NSSC23CA171: E014042 Sbir Phase III Rapid, Low-Cost Nanoligomertm Based Drug-Discovery in Space
Creator: SpendQuery
License: https://www.usa.gov/government-works

E014042 SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE

Definitive Contract · National Aeronautics and Space Administration · to Sachi Bioworks, Inc. (UEI NTKPGKZLXPC1) · data as of 2026-10-20

Obligated to date$5.45M12 actions

Current value$9.60Mwith options exercised

Period2023-07-10 → 2028-07-19current end date

Up for re-bid: ends 2028-07-19. Recompete brief →

What it is

Product or service: General Science & Technology R&D Svcs General Science & Technology; R&D Administrative Expenses (PSC AJ14)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: Nasa Shared Services Center (80NSSC)
Competition: Full and open after exclusion of sources · 500 offers received
Set-aside: Small business
Pricing: Firm fixed price
How it was bought: Standalone contract
Where the work is: Boulder, CO · district CO-02

Obligations by fiscal year

FY2023$995.2K

FY2024$0

FY2025$600.0K

FY2026$3.85M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

12 actions since 2023-07-10. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-08-20	P00011	Administrative change	$0	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2026-06-30	P00010	Administrative change	$0	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2026-06-16	P00009	Funding only	$1.85M	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2026-04-07	P00008	Administrative change	$0	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2026-02-24	P00007	Additional work (new agreement)	$1.40M	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2026-01-26	P00006	Administrative change	$0	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2026-01-15	P00005	Additional work (new agreement)	$600.0K	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2025-03-27	P00004	Administrative change	$0	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2025-01-29	P00003	Additional work (new agreement)	$600.0K	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2024-07-30	P00002	Administrative change	$0	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2023-10-24	P00001	Administrative change	$0	SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
2023-07-10	0		$995.2K	E014042 SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-20). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…